Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Cash (2016 - 2025)

Icu Medical (ICUI) has disclosed Change in Cash for 17 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 308.59% year-over-year to $8.2 million, compared with a TTM value of -$603000.0 through Dec 2025, down 101.11%, and an annual FY2025 reading of -$603000.0, down 101.11% over the prior year.
  • Change in Cash was $8.2 million for Q4 2025 at Icu Medical, up from -$293000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $57.4 million in Q3 2021 and bottomed at -$223.4 million in Q1 2022.
  • Average Change in Cash over 5 years is -$4.4 million, with a median of $4.8 million recorded in 2023.
  • The sharpest move saw Change in Cash tumbled 893.55% in 2022, then skyrocketed 655.86% in 2024.
  • Year by year, Change in Cash stood at $33.3 million in 2021, then tumbled by 205.26% to -$35.1 million in 2022, then skyrocketed by 262.5% to $57.0 million in 2023, then tumbled by 106.92% to -$3.9 million in 2024, then soared by 308.59% to $8.2 million in 2025.
  • Business Quant data shows Change in Cash for ICUI at $8.2 million in Q4 2025, -$293000.0 in Q3 2025, and $10.3 million in Q2 2025.